SELLAS Life Sciences Group, Inc. (SLS)
(Delayed Data from NSDQ)
$1.62 USD
+0.03 (1.89%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.63 +0.01 (0.62%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, SELLAS Life Sciences Group, Inc. has a market cap of $158.65M, which represents its share price of $1.59 multiplied by its outstanding shares number of 99.78M. As a small-cap company, SLS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SLS 1.62 +0.03(1.89%)
Will SLS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLS
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
Galena Biopharma (SLS) Upgraded to Buy: What Does It Mean for the Stock?
SLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galena Biopharma (SLS) Upgraded to Buy: Here's Why
Other News for SLS
Vanguard Group Inc's Strategic Acquisition in SELLAS Life Sciences Group Inc
Maxim Increases Price Target for Sellas Life Sciences (SLS) | SLS Stock News
Sellas Life Sciences price target raised by $3 at Maxim, here's why
SLS Stock: Maxim Group Raises Price Target by 75% to $7.00 | SLS Stock News
SELLAS Life Sciences (SLS) Rises on Promising AML Trial Results